LU87681A1 - Compositions pharmaceutiques - Google Patents

Compositions pharmaceutiques Download PDF

Info

Publication number
LU87681A1
LU87681A1 LU87681A LU87681A LU87681A1 LU 87681 A1 LU87681 A1 LU 87681A1 LU 87681 A LU87681 A LU 87681A LU 87681 A LU87681 A LU 87681A LU 87681 A1 LU87681 A1 LU 87681A1
Authority
LU
Luxembourg
Prior art keywords
filling
pharmaceutical composition
fatty acids
ranitidine
mixture
Prior art date
Application number
LU87681A
Other languages
English (en)
French (fr)
Inventor
Sham Kumar Chopra
Tarun Tribhovan Makadia
Original Assignee
Glaxo Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Canada filed Critical Glaxo Canada
Publication of LU87681A1 publication Critical patent/LU87681A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LU87681A 1989-02-23 1990-02-21 Compositions pharmaceutiques LU87681A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898904182A GB8904182D0 (en) 1989-02-23 1989-02-23 Pharmaceutical compositions
GB8904182 1989-02-23

Publications (1)

Publication Number Publication Date
LU87681A1 true LU87681A1 (fr) 1991-10-08

Family

ID=10652220

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87681A LU87681A1 (fr) 1989-02-23 1990-02-21 Compositions pharmaceutiques

Country Status (26)

Country Link
US (1) US5028432A (de)
JP (1) JP2856817B2 (de)
KR (1) KR940006271B1 (de)
AT (1) AT401727B (de)
AU (1) AU629303B2 (de)
BE (1) BE1003123A3 (de)
CA (1) CA2010692C (de)
CH (1) CH680567A5 (de)
CY (1) CY1734A (de)
DE (1) DE4005650C2 (de)
DK (1) DK170209B1 (de)
FR (1) FR2643263B1 (de)
GB (2) GB8904182D0 (de)
HK (1) HK89493A (de)
HU (1) HU211930A9 (de)
IE (1) IE63179B1 (de)
IL (1) IL93490A (de)
IT (1) IT1240768B (de)
LU (1) LU87681A1 (de)
NL (1) NL193267C (de)
NZ (1) NZ232642A (de)
PH (1) PH26972A (de)
SA (1) SA90100287B1 (de)
SE (1) SE512412C2 (de)
ZA (1) ZA901348B (de)
ZW (1) ZW1790A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004893A1 (en) * 1990-09-13 1992-04-02 Smithkline Beecham Corporation Non-aqueous liquid oral suspensions
US5571533A (en) * 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
AU669952B2 (en) * 1992-10-16 1996-06-27 Glaxo Group Limited Taste-masking compositions of ranitidine
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
DE4341310A1 (de) * 1993-12-03 1995-06-08 Hexal Pharma Gmbh Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
GB9705813D0 (en) * 1997-03-20 1997-05-07 Smithkline Beecham Plc Novel compositions
AR013261A1 (es) * 1997-08-01 2000-12-13 Smithkline Beecham Corp Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
ATE374602T1 (de) * 2001-12-21 2007-10-15 Supernus Pharmaceuticals Inc Orale kapselformulierung mit verbesserter physikalischer stabilität
JP2006518380A (ja) * 2003-01-31 2006-08-10 スミスクライン・ビーチャム・コーポレイション 固体分散体組成物
KR101152470B1 (ko) 2003-08-13 2012-06-01 바이오콘 리미티드 치료제용 마이크로-입자 지방산 염 고형 투약 제형
MX2012013955A (es) 2010-06-23 2013-01-24 Colgate Palmolive Co Composiciones terapeuticas bucales.
US9161891B2 (en) 2010-12-20 2015-10-20 Colgate-Palmolive Company Gelatin encapsulated oral care composition containing dental occlusion actives, hydrophobic viscosity modifier and oil carrier
CN107088168A (zh) 2010-12-20 2017-08-25 高露洁-棕榄公司 包含牙齿封闭活性物的非水性口腔护理组合物
CN103260466B (zh) 2010-12-20 2016-08-17 高露洁-棕榄公司 含有亲水性活性物质、疏水性结构化剂和油载体的明胶包囊的口腔护理组合物
US20200038376A1 (en) * 2016-11-01 2020-02-06 Johnson & Johnson Consumer Inc. Liquid oral pharmaceutical dosage form comprising an histamine h2-receptor antagonist and an antacid
CN109010303B (zh) * 2017-06-09 2021-05-07 苏州科伦药物研究有限公司 一种盐酸雷尼替丁胶囊的工业制备方法
KR102108153B1 (ko) * 2017-07-05 2020-05-07 (주)동구바이오제약 생체 이용률 및 안정성이 개선된 레티노이드를 함유하는 약제학적 조성물
KR102928295B1 (ko) * 2018-09-07 2026-02-13 알.피.쉐러 테크놀러지즈 엘엘씨 경화 및 낮은 hlb 계면 활성제(들)의 첨가를 통한 고체 또는 반고체 지질 기반 제형 안정화

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374146A (en) * 1966-04-18 1968-03-19 American Cyanamid Co Sustained release encapsulation
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IT1090703B (it) * 1976-12-03 1985-06-26 Scherer Ltd R P Perfezionamento nelle composizioni utili quali veicolo per farmaci
JPS5919524B2 (ja) * 1976-12-17 1984-05-07 中外製薬株式会社 安定な１α−ヒドロキシビタミンＤ類含有製剤
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
JPS55136219A (en) * 1979-04-11 1980-10-23 Sumitomo Chem Co Ltd Diazepam oily drug
EP0040489A1 (de) * 1980-05-17 1981-11-25 FISONS plc Mischungen, Salze, Packungen und pharmazeutische Zusammensetzungen mit Gehalt an 5-(2-Hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carbonsäure oder einem Derivat derselben und einem H2-Rezeptoren antagonisierenden Antihistamin
GB2084580B (en) * 1980-10-01 1984-07-04 Glaxo Group Ltd Aminoalkyl furan derivative
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
DE3264782D1 (en) * 1981-10-16 1985-08-22 Sanol Arznei Schwarz Gmbh Medicinal formulation
JPS58174308A (ja) * 1982-04-06 1983-10-13 Fujimoto Seiyaku Kk レクタルカプセル坐剤
CA1211374A (en) * 1982-05-14 1986-09-16 Eszter Cholnoky Pharmaceutical compositions containing more active ingredients
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
EP0152432B1 (de) * 1983-08-01 1989-03-01 R.P. Scherer Corporation Verfahren und erzeugnis zur verzögerten freigabe
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
GB8426738D0 (en) * 1984-10-23 1984-11-28 Scras Pyridine derivatives
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
JPH07549B2 (ja) * 1986-07-03 1995-01-11 ゼリア新薬工業株式会社 軟カプセル充填用組成物
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
JPH0482832A (ja) * 1988-09-20 1992-03-16 Glaxo Group Ltd 医薬組成物

Also Published As

Publication number Publication date
US5028432A (en) 1991-07-02
BE1003123A3 (fr) 1991-12-03
SA90100287B1 (ar) 1999-08-15
IL93490A (en) 1994-07-31
CA2010692A1 (en) 1990-08-23
JP2856817B2 (ja) 1999-02-10
IT9047659A0 (it) 1990-02-22
IE63179B1 (en) 1995-03-22
HU211930A9 (en) 1996-01-29
FR2643263B1 (fr) 1994-09-16
NL9000428A (nl) 1990-09-17
ZW1790A1 (en) 1991-10-16
GB9004016D0 (en) 1990-04-18
IE900651L (en) 1990-08-23
HK89493A (en) 1993-09-03
KR940006271B1 (ko) 1994-07-14
PH26972A (en) 1992-12-28
DK48090A (da) 1990-08-24
DE4005650A1 (de) 1990-09-06
NZ232642A (en) 1992-07-28
SE9000625D0 (sv) 1990-02-22
CA2010692C (en) 1995-12-12
GB2229094A (en) 1990-09-19
DE4005650C2 (de) 1999-03-25
SE512412C2 (sv) 2000-03-13
GB8904182D0 (en) 1989-04-05
IT1240768B (it) 1993-12-17
ATA42190A (de) 1996-04-15
GB2229094B (en) 1993-01-06
IL93490A0 (en) 1990-11-29
NL193267C (nl) 1999-05-06
IT9047659A1 (it) 1991-08-22
JPH03200728A (ja) 1991-09-02
SE9000625L (sv) 1990-08-24
DK170209B1 (da) 1995-06-19
AU629303B2 (en) 1992-10-01
ZA901348B (en) 1991-03-27
CY1734A (en) 1994-05-06
DK48090D0 (da) 1990-02-22
NL193267B (nl) 1999-01-04
KR900012612A (ko) 1990-09-01
AU5007390A (en) 1990-08-30
CH680567A5 (de) 1992-09-30
FR2643263A1 (fr) 1990-08-24
AT401727B (de) 1996-11-25

Similar Documents

Publication Publication Date Title
CH680567A5 (de)
CA2231342C (fr) Composition pharmaceutique pour administration par voie orale
WO1998043635A1 (fr) Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino- 3-pyrazolecarboxamide, de ses sels et de leurs solvates
FR2753376A1 (fr) Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
CA2470443A1 (fr) Compositions pharmaceutiques a base de derives d'azetidine
EP1165042B1 (de) Trinkbare pharmazeutische suspension von ibuprofen
WO1999012528A1 (fr) Capsules semi-solides autoemulsionnables matricielles a action prolongee
WO1997021440A1 (en) A solution for oral administration containing ici 182,780
EP0356325B1 (de) Einen in Wasser schwerlöslichen Wirkstoff und mindestens ein durch mindestens ein Zellulosepolymer geliertes Glycerid enthaltende pharmazeutische Zubereitungen
CA2074726A1 (fr) Gelule huileuse de ketoprofene
EP0265338B1 (de) Beständige therapeutische Zusammensetzungen, basierend auf hydrophobem pflanzlichem Öl und Verfahren zu ihrer Herstellung
LU87233A1 (fr) Composition pharmaceutique a base d'un anti-inflammatoire non steroidien,son procede de preparation et son utilisation
EP1165043A1 (de) Trinkbare pharmazeutische suspension
EP1286660B1 (de) Flüssige arzneizubereitungen für die orale verabreichung von unangenehm, bitterschmeckenden arzneimitteln
FR2913884A1 (fr) Systeme galenique hydrophobe non ionisable
WO2001066109A1 (fr) Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline